MX2007000566A - Sintesis bioquimica de 1,4- butanodiamina. - Google Patents
Sintesis bioquimica de 1,4- butanodiamina.Info
- Publication number
- MX2007000566A MX2007000566A MX2007000566A MX2007000566A MX2007000566A MX 2007000566 A MX2007000566 A MX 2007000566A MX 2007000566 A MX2007000566 A MX 2007000566A MX 2007000566 A MX2007000566 A MX 2007000566A MX 2007000566 A MX2007000566 A MX 2007000566A
- Authority
- MX
- Mexico
- Prior art keywords
- gene
- process according
- expressed
- ornithine decarboxylase
- decarboxylase
- Prior art date
Links
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 32
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 22
- 108700005126 Ornithine decarboxylases Proteins 0.000 claims abstract description 81
- 102000052812 Ornithine decarboxylases Human genes 0.000 claims abstract description 77
- 238000000034 method Methods 0.000 claims abstract description 69
- 230000008569 process Effects 0.000 claims abstract description 52
- 230000001965 increasing effect Effects 0.000 claims abstract description 51
- 230000000694 effects Effects 0.000 claims abstract description 41
- 239000013612 plasmid Substances 0.000 claims abstract description 23
- 244000005700 microbiome Species 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 13
- 230000004151 fermentation Effects 0.000 claims abstract description 13
- 102100021079 Ornithine decarboxylase Human genes 0.000 claims abstract description 7
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 claims abstract description 7
- 239000013598 vector Substances 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 74
- 241000588724 Escherichia coli Species 0.000 claims description 38
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 102100032252 Antizyme inhibitor 2 Human genes 0.000 claims description 24
- 102000011229 agmatinase Human genes 0.000 claims description 24
- 101000652415 Homo sapiens Agmatinase, mitochondrial Proteins 0.000 claims description 21
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 claims description 21
- 101000711499 Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1) N(1)-aminopropylagmatine ureohydrolase Proteins 0.000 claims description 21
- 108090000531 Amidohydrolases Proteins 0.000 claims description 19
- 102000004092 Amidohydrolases Human genes 0.000 claims description 18
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 18
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 18
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 18
- 229960003104 ornithine Drugs 0.000 claims description 18
- 230000002103 transcriptional effect Effects 0.000 claims description 17
- 101150022778 speF gene Proteins 0.000 claims description 16
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 15
- 108700024157 Agmatine deiminases Proteins 0.000 claims description 12
- 230000002255 enzymatic effect Effects 0.000 claims description 12
- 101150044368 speC gene Proteins 0.000 claims description 12
- 230000002018 overexpression Effects 0.000 claims description 11
- 241000894007 species Species 0.000 claims description 11
- 241000607142 Salmonella Species 0.000 claims description 10
- 101150101115 speB gene Proteins 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 9
- 101150038942 speA gene Proteins 0.000 claims description 9
- 210000003705 ribosome Anatomy 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 241000588722 Escherichia Species 0.000 claims description 6
- 101150047781 ptcA gene Proteins 0.000 claims description 6
- 241000186249 Corynebacterium sp. Species 0.000 claims description 5
- 241000488157 Escherichia sp. Species 0.000 claims description 5
- 241000588653 Neisseria Species 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
- 241001148062 Photorhabdus Species 0.000 claims description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 4
- 241001223867 Shewanella oneidensis Species 0.000 claims description 4
- 241000607768 Shigella Species 0.000 claims description 4
- 241000607762 Shigella flexneri Species 0.000 claims description 4
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 4
- QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 claims description 3
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 3
- 241000588650 Neisseria meningitidis Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 claims description 3
- 241000219194 Arabidopsis Species 0.000 claims description 2
- 241000589151 Azotobacter Species 0.000 claims description 2
- 241000589149 Azotobacter vinelandii Species 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000193755 Bacillus cereus Species 0.000 claims description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 2
- 108091026890 Coding region Proteins 0.000 claims description 2
- 241000383839 Novosphingobium Species 0.000 claims description 2
- 241000233540 Novosphingobium aromaticivorans Species 0.000 claims description 2
- 241000606860 Pasteurella Species 0.000 claims description 2
- 241000606856 Pasteurella multocida Species 0.000 claims description 2
- 241000235061 Pichia sp. Species 0.000 claims description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 claims description 2
- 241000588770 Proteus mirabilis Species 0.000 claims description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 2
- 241000235088 Saccharomyces sp. Species 0.000 claims description 2
- 241000863430 Shewanella Species 0.000 claims description 2
- 241000194019 Streptococcus mutans Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000607598 Vibrio Species 0.000 claims description 2
- 241000607626 Vibrio cholerae Species 0.000 claims description 2
- 230000037041 intracellular level Effects 0.000 claims description 2
- 108020004999 messenger RNA Proteins 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 229940118696 vibrio cholerae Drugs 0.000 claims description 2
- 102000004031 Carboxy-Lyases Human genes 0.000 claims 1
- 108090000489 Carboxy-Lyases Proteins 0.000 claims 1
- 241001468227 Streptomyces avermitilis Species 0.000 claims 1
- 101150071766 aguA gene Proteins 0.000 claims 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 12
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 229920000768 polyamine Polymers 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 238000010276 construction Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 238000012261 overproduction Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 108090000794 Streptopain Proteins 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000004475 Arginine Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000006142 Luria-Bertani Agar Substances 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 230000003851 biochemical process Effects 0.000 description 5
- 239000013611 chromosomal DNA Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 229940063673 spermidine Drugs 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 108010054278 Lac Repressors Proteins 0.000 description 4
- 230000036983 biotransformation Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 108700016258 Agmatinases Proteins 0.000 description 3
- 108700016156 Arginine decarboxylases Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YANFYYGANIYHGI-UHFFFAOYSA-N N-carbamoylputrescine Chemical compound NCCCCNC(N)=O YANFYYGANIYHGI-UHFFFAOYSA-N 0.000 description 3
- 229920001007 Nylon 4 Polymers 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 239000005700 Putrescine Substances 0.000 description 3
- 241001415395 Spea Species 0.000 description 3
- 101150084989 Speg gene Proteins 0.000 description 3
- 241000149010 Thespea Species 0.000 description 3
- 230000002210 biocatalytic effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000011191 terminal modification Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 101710170109 Constitutive ornithine decarboxylase Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229920003189 Nylon 4,6 Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
- KIMDLKLVWNOEAU-UHFFFAOYSA-N 4-(3-aminopropyl)heptane-1,4,7-triamine Chemical compound NCCCC(N)(CCCN)CCCN KIMDLKLVWNOEAU-UHFFFAOYSA-N 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010077448 Diamine N-acetyltransferase Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 101710088686 Inducible ornithine decarboxylase Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 108050007429 Ornithine decarboxylase SpeF Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101710180958 Putative aminoacrylate hydrolase RutD Proteins 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BIGPRXCJEDHCLP-UHFFFAOYSA-N ammonium bisulfate Chemical compound [NH4+].OS([O-])(=O)=O BIGPRXCJEDHCLP-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006012 detection of carbon dioxide Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077046 | 2004-07-15 | ||
| PCT/EP2005/007606 WO2006005603A1 (en) | 2004-07-15 | 2005-07-11 | Biochemical synthesis of 1,4-butanediamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007000566A true MX2007000566A (es) | 2007-04-02 |
Family
ID=34928370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007000566A MX2007000566A (es) | 2004-07-15 | 2005-07-11 | Sintesis bioquimica de 1,4- butanodiamina. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8497098B2 (https=) |
| EP (2) | EP2949755B1 (https=) |
| JP (1) | JP4836948B2 (https=) |
| CN (1) | CN101010433B (https=) |
| AU (1) | AU2005261861B2 (https=) |
| BR (1) | BRPI0513343B1 (https=) |
| CA (1) | CA2571528C (https=) |
| DK (1) | DK1784496T3 (https=) |
| EA (1) | EA010179B1 (https=) |
| ES (1) | ES2581244T3 (https=) |
| IN (1) | IN2007DE00479A (https=) |
| MX (1) | MX2007000566A (https=) |
| MY (1) | MY152156A (https=) |
| NZ (1) | NZ552631A (https=) |
| TW (1) | TWI346139B (https=) |
| UA (1) | UA90479C2 (https=) |
| WO (1) | WO2006005603A1 (https=) |
| ZA (1) | ZA200700104B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0714842A2 (pt) | 2006-08-01 | 2013-05-21 | Basf Se | processo para preparar um composto, composto, e, uso do composto |
| CN101063144B (zh) * | 2007-05-10 | 2010-09-15 | 南京农业大学 | 乳酸菌谷氨酸脱羧酶基因的克隆、表达及应用 |
| CA2718258C (en) | 2008-03-12 | 2016-12-13 | Toray Industries, Inc. | Method for producing diamine and polyamide |
| MY175283A (en) * | 2008-04-10 | 2020-06-18 | Korea Advanced Inst Sci & Tech | Mutant microorganisms having high ability to produce putrescine and method for producing putrescine using the same |
| FR2933414B1 (fr) * | 2008-07-07 | 2010-08-13 | Arkema France | Polyamide, composition comprenant un tel polyamide et leurs utilisations |
| JP5776907B2 (ja) * | 2009-07-24 | 2015-09-09 | ディーエスエム アイピー アセッツ ビー．ブイ． | Ｎ−アシル保護またはｎ−グアニジル保護１，４−ブタンジアミン前駆体を介する１，４−ブタンジアミンの調製方法 |
| KR20120083908A (ko) * | 2009-10-13 | 2012-07-26 | 게노마티카 인코포레이티드 | 1,4-부탄다이올, 4-하이드록시부탄알, 4-하이드록시부티릴-ｃｏａ, 푸트레신 및 관련 화합물의 제조를 위한 미생물 및 관련 방법 |
| KR101174267B1 (ko) * | 2010-01-06 | 2012-08-14 | 씨제이제일제당 (주) | Ｌ-오르니틴 또는 ｌ-아르기닌 생산 변이주 및 이의 제조방법 |
| KR101348461B1 (ko) * | 2010-12-08 | 2014-01-08 | 씨제이제일제당 (주) | 퓨트레신을 생산하는 미생물 및 이를 이용하여 퓨트레신을 생산하는 방법 |
| KR101286158B1 (ko) * | 2011-08-24 | 2013-07-15 | 씨제이제일제당 (주) | 발효액에서 1,4-디아미노부탄의 분리 및 정제하는 방법 |
| AU2013208344B2 (en) * | 2012-01-11 | 2016-06-30 | Cj Cheiljedang Corporation | Recombinant Microorganisms With An Improved Productivity Of Putrescine And Method For Producing Putrescine Using The Same |
| PL2806022T3 (pl) * | 2012-01-20 | 2018-12-31 | Cj Cheiljedang Corporation | Rekombinowany mikroorganizm z poprawioną zdolnością do wytwarzania putrescyny oraz sposób wytwarzania putrescyny z jego zastosowaniem |
| KR20140052189A (ko) * | 2012-10-22 | 2014-05-07 | 씨제이제일제당 (주) | 1,4-디아미노부탄의 정제방법, 상기 방법으로 정제된 1,4-디아미노부탄 및 이로부터 제조되는 폴리아미드 |
| KR101607741B1 (ko) * | 2013-03-20 | 2016-03-31 | 씨제이제일제당 (주) | 퓨트레신 생산 재조합 미생물 및 이를 이용한 퓨트레신 생산방법 |
| KR101835164B1 (ko) * | 2013-07-17 | 2018-03-06 | 씨제이제일제당 (주) | 향상된 퓨트레신 생산능을 가지는 변이된 오르니틴 디카복실레이즈 단백질 및 이의 용도 |
| CN103951504A (zh) * | 2014-04-21 | 2014-07-30 | 扬州市嘉康菇业发展有限公司 | 一种促进金针菇菌丝体快速生长的培养基的制备方法 |
| JP6526791B2 (ja) | 2014-04-25 | 2019-06-05 | シージェイ チェイルジェダン コーポレーション | ジアミンを生産する微生物及びそれらを用いてジアミンを生産する方法 |
| AU2015250431B2 (en) | 2014-04-25 | 2017-09-28 | Cj Cheiljedang Corporation | Microorganisms for Producing Putrescine and Process for Producing Putrescine Using Them |
| EP3135757B1 (en) | 2014-04-25 | 2019-02-20 | CJ Cheiljedang Corporation | Diamine-producing microorganism and method for producing diamine using same |
| JP2017158434A (ja) * | 2014-07-22 | 2017-09-14 | 協同乳業株式会社 | バクテリア混合培養によるプトレッシン製造方法 |
| KR101813759B1 (ko) | 2015-06-24 | 2018-01-02 | 씨제이제일제당 (주) | 퓨트레신 또는 오르니틴 생산 미생물 및 이를 이용한 퓨트레신 또는 오르니틴 생산방법 |
| KR101735935B1 (ko) | 2015-07-20 | 2017-05-16 | 씨제이제일제당 (주) | 퓨트레신 또는 오르니틴 생산 미생물 및 이를 이용한 퓨트레신 또는 오르니틴 생산방법 |
| KR102011394B1 (ko) | 2017-07-19 | 2019-10-22 | 씨제이제일제당 주식회사 | 퓨트레신을 생산하는 미생물 및 이를 이용한 퓨트레신 생산방법 |
| EP3808848A1 (en) | 2019-10-14 | 2021-04-21 | Eberhard Karls Universität Tübingen | Regulatory element of an arginine decarboxylase gene and methods and uses thereof |
| KR102246288B1 (ko) | 2020-08-13 | 2021-04-29 | 씨제이제일제당 주식회사 | 퓨트레신 생산 미생물 및 이를 이용한 퓨트레신 생산방법 |
| CN113061562B (zh) * | 2021-03-22 | 2022-09-27 | 江南大学 | 一种利用钝齿棒杆菌发酵生产1,4-丁二胺的方法 |
| CN117736951B (zh) * | 2023-11-27 | 2026-03-03 | 天津科技大学 | 生产1,4-丁二胺的大肠杆菌底盘菌株及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2130948A (en) | 1937-04-09 | 1938-09-20 | Du Pont | Synthetic fiber |
| ES2088826B1 (es) | 1995-02-10 | 1997-06-01 | Taguidell Sociedad Limitada | Procedimiento de obtencion de las diaminas putrescina y cadaverina a partir de productos naturales tratados, su uso como aditivo en abonos, y abono correspondiente. |
| AU6464100A (en) | 1999-08-10 | 2001-03-05 | John Innes Centre | Polyamine accumulation in plants |
| JP2002345496A (ja) | 2001-05-25 | 2002-12-03 | Ajinomoto Co Inc | アグマチンの製造方法およびアルギニン脱炭酸酵素の製造方法 |
-
2005
- 2005-07-11 CN CN2005800236901A patent/CN101010433B/zh not_active Expired - Fee Related
- 2005-07-11 CA CA2571528A patent/CA2571528C/en not_active Expired - Fee Related
- 2005-07-11 AU AU2005261861A patent/AU2005261861B2/en not_active Ceased
- 2005-07-11 EP EP15175520.4A patent/EP2949755B1/en not_active Expired - Lifetime
- 2005-07-11 EA EA200700329A patent/EA010179B1/ru not_active IP Right Cessation
- 2005-07-11 BR BRPI0513343-2A patent/BRPI0513343B1/pt not_active IP Right Cessation
- 2005-07-11 NZ NZ552631A patent/NZ552631A/en not_active IP Right Cessation
- 2005-07-11 MX MX2007000566A patent/MX2007000566A/es active IP Right Grant
- 2005-07-11 DK DK05767851.8T patent/DK1784496T3/en active
- 2005-07-11 ES ES05767851.8T patent/ES2581244T3/es not_active Expired - Lifetime
- 2005-07-11 US US11/632,458 patent/US8497098B2/en not_active Expired - Fee Related
- 2005-07-11 UA UAA200701584A patent/UA90479C2/ru unknown
- 2005-07-11 WO PCT/EP2005/007606 patent/WO2006005603A1/en not_active Ceased
- 2005-07-11 JP JP2007520744A patent/JP4836948B2/ja not_active Expired - Fee Related
- 2005-07-11 EP EP05767851.8A patent/EP1784496B1/en not_active Expired - Lifetime
- 2005-07-15 TW TW094124157A patent/TWI346139B/zh not_active IP Right Cessation
- 2005-07-15 MY MYPI20053244 patent/MY152156A/en unknown
-
2007
- 2007-01-03 ZA ZA200700104A patent/ZA200700104B/en unknown
- 2007-01-17 IN IN479DE2007 patent/IN2007DE00479A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0513343A (pt) | 2008-05-06 |
| CA2571528A1 (en) | 2006-01-19 |
| ES2581244T3 (es) | 2016-09-02 |
| AU2005261861B2 (en) | 2010-08-26 |
| UA90479C2 (en) | 2010-05-11 |
| AU2005261861A1 (en) | 2006-01-19 |
| TWI346139B (en) | 2011-08-01 |
| EA010179B1 (ru) | 2008-06-30 |
| CN101010433A (zh) | 2007-08-01 |
| NZ552631A (en) | 2009-09-25 |
| EP2949755A1 (en) | 2015-12-02 |
| EP1784496B1 (en) | 2016-04-06 |
| EP1784496A1 (en) | 2007-05-16 |
| TW200605869A (en) | 2006-02-16 |
| CN101010433B (zh) | 2012-03-07 |
| ZA200700104B (en) | 2008-05-28 |
| JP2008505651A (ja) | 2008-02-28 |
| WO2006005603A1 (en) | 2006-01-19 |
| MY152156A (en) | 2014-08-15 |
| US8497098B2 (en) | 2013-07-30 |
| EA200700329A1 (ru) | 2007-08-31 |
| IN2007DE00479A (https=) | 2007-08-17 |
| JP4836948B2 (ja) | 2011-12-14 |
| CA2571528C (en) | 2016-02-16 |
| EP2949755B1 (en) | 2018-03-28 |
| US20090011478A1 (en) | 2009-01-08 |
| DK1784496T3 (en) | 2016-07-25 |
| BRPI0513343B1 (pt) | 2020-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007000566A (es) | Sintesis bioquimica de 1,4- butanodiamina. | |
| Jorge et al. | A new metabolic route for the production of gamma-aminobutyric acid by Corynebacterium glutamicum from glucose | |
| EP2593556B1 (en) | Enzymatic method for (r)-selective amination | |
| US20160319311A1 (en) | Biochemical synthesis of 1,4-butanediamine | |
| JP2022530475A (ja) | 遺伝子操作された微生物及びアルデヒド脱水素酵素活性の改善方法 | |
| CN116783281A (zh) | 用于制备酰胺化合物的方法和组合物 | |
| Pérez-García | Microbial Production of Diamines | |
| BRPI0513362B1 (pt) | Process for obtaining 1,4-butanodiamine in a fermentation process | |
| HK1185919A (en) | (r)-selective amination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |